TELIX PHARMACEUTICALS LIMITED
Last · —A$15.08-0.26 (-1.69%)live · yahoo · 0s ago
Vol 1.75M ≈ 26.36M
MA10MA20MA50
Market capA$5.1B338.8M sh
P/E · TTM101fwd — · eps 0.15
Beta—vs S&P 500
Div yield0.00%annual · TTM
52w range
A$8.63A$17.85
Volume1.7Msession
Issuer
Legal nameTELIX PHARMACEUTICALS LIMITED
HQAustralia (AU)
ListingAU TLX
ISINAU000000TLX2
SectorHealthcare
IndustryBiotechnology & Medical Research
CurrencyAUD
Entity registryisin:AU000000TLX2
CIK0002007191
Websitetelixpharma.com
Employees1,152
AddressTelix Pharmaceuticals Ltd. 55 Flemington Road 3051, Melbourne
Loading chart…
Press & signals
- GlobeNewswire
Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse
- GlobeNewswire
Telix Appoints David Gill as Chair
- GlobeNewswire
Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline
The rest of this company's wire — with summaries and source links — is part of Pro.
See plansDocuments
FormReporting forFiledFlags
Showing 5 of 81 filings